A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Marburg Virus Vaccine in Healthy Adults
Clinical trial NCT06620003 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06620003
- Sponsor
- Albert B. Sabin Vaccine Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-14
- Primary completion
- 2026-10-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.